- Home
- UBX vs IBIO Comparison
UBX vs IBIO Comparison
Compare UBX & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBX
- IBIO
- Stock Information
- Founded
- UBX 2009
- IBIO 2008
- Country
- UBX United States
- IBIO United States
- Employees
- UBX N/A
- IBIO N/A
- Industry
- UBX Biotechnology: Pharmaceutical Preparations
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- UBX Health Care
- IBIO Health Care
- Exchange
- UBX Nasdaq
- IBIO Nasdaq
- Market Cap
- UBX 13.9M
- IBIO 15.9M
- IPO Year
- UBX 2018
- IBIO N/A
- Fundamental
- Price
- UBX $0.78
- IBIO $0.71
- Analyst Decision
- UBX Strong Buy
- IBIO Strong Buy
- Analyst Count
- UBX 3
- IBIO 3
- Target Price
- UBX $4.67
- IBIO $4.87
- AVG Volume (30 Days)
- UBX 521.0K
- IBIO 5.3M
- Earning Date
- UBX 08-05-2025
- IBIO 05-02-2025
- Dividend Yield
- UBX N/A
- IBIO N/A
- EPS Growth
- UBX N/A
- IBIO N/A
- EPS
- UBX N/A
- IBIO N/A
- Revenue
- UBX N/A
- IBIO $375,000.00
- Revenue This Year
- UBX N/A
- IBIO $36.00
- Revenue Next Year
- UBX N/A
- IBIO N/A
- P/E Ratio
- UBX N/A
- IBIO N/A
- Revenue Growth
- UBX N/A
- IBIO 650.00
- 52 Week Low
- UBX $0.66
- IBIO $0.64
- 52 Week High
- UBX $3.10
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- UBX 48.12
- IBIO 37.70
- Support Level
- UBX $0.67
- IBIO $0.68
- Resistance Level
- UBX $0.83
- IBIO $1.04
- Average True Range (ATR)
- UBX 0.09
- IBIO 0.12
- MACD
- UBX 0.01
- IBIO -0.00
- Stochastic Oscillator
- UBX 24.67
- IBIO 7.89
About UBX Unity Biotechnology Inc.
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.